{"title":"妊娠期肾积水：决定导尿管使用的关键因素。","authors":"Çağdaş Demiroğlu, Mehmet Solakhan","doi":"10.1177/1753495X251332667","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pregnancy causes physiological changes, including ureteral compression by the enlarged uterus, leading to hydronephrosis in 90% of cases, though only 3% are symptomatic. This study evaluates outcomes in pregnant women with hydronephrosis managed with or without ureteral stenting to define criteria for intervention.</p><p><strong>Methods: </strong>A retrospective analysis of 92 symptomatic pregnant women with hydronephrosis diagnosed at MP Hospital (2019-2024) was conducted. Patients were categorized into conservative treatment (Group I) and stenting (Group II). Renal dilation, parenchymal thickness, and infection status were assessed.</p><p><strong>Results: </strong>Patients in Group II also had hydronephrosis at earlier gestational weeks (<i>p</i> < .001), and also had more male fetuses (<i>p</i> = .033), lower parenchymal thickness (<i>p</i> < .001), and higher infection rates (<i>p</i> < .001).</p><p><strong>Conclusion: </strong>Indicators for stenting in pregnancy-related hydronephrosis include parenchymal thickness ≤20 mm, renal dilation >30 mm, early symptoms, and infections.</p>","PeriodicalId":51717,"journal":{"name":"Obstetric Medicine","volume":" ","pages":"1753495X251332667"},"PeriodicalIF":0.5000,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12187711/pdf/","citationCount":"0","resultStr":"{\"title\":\"Hydronephrosis in pregnancy: Critical factors determining urinary catheter use.\",\"authors\":\"Çağdaş Demiroğlu, Mehmet Solakhan\",\"doi\":\"10.1177/1753495X251332667\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Pregnancy causes physiological changes, including ureteral compression by the enlarged uterus, leading to hydronephrosis in 90% of cases, though only 3% are symptomatic. This study evaluates outcomes in pregnant women with hydronephrosis managed with or without ureteral stenting to define criteria for intervention.</p><p><strong>Methods: </strong>A retrospective analysis of 92 symptomatic pregnant women with hydronephrosis diagnosed at MP Hospital (2019-2024) was conducted. Patients were categorized into conservative treatment (Group I) and stenting (Group II). Renal dilation, parenchymal thickness, and infection status were assessed.</p><p><strong>Results: </strong>Patients in Group II also had hydronephrosis at earlier gestational weeks (<i>p</i> < .001), and also had more male fetuses (<i>p</i> = .033), lower parenchymal thickness (<i>p</i> < .001), and higher infection rates (<i>p</i> < .001).</p><p><strong>Conclusion: </strong>Indicators for stenting in pregnancy-related hydronephrosis include parenchymal thickness ≤20 mm, renal dilation >30 mm, early symptoms, and infections.</p>\",\"PeriodicalId\":51717,\"journal\":{\"name\":\"Obstetric Medicine\",\"volume\":\" \",\"pages\":\"1753495X251332667\"},\"PeriodicalIF\":0.5000,\"publicationDate\":\"2025-06-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12187711/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Obstetric Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/1753495X251332667\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetric Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1753495X251332667","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景：妊娠引起生理变化，包括子宫增大对输尿管的压迫，导致90%的病例肾积水，但只有3%的病例有症状。本研究评估了采用输尿管支架置入或不采用输尿管支架置入治疗肾积水的孕妇的结局，以确定干预标准。方法：对2019-2024年在MP医院确诊的92例有症状的妊娠肾积水患者进行回顾性分析。患者分为保守治疗组（I组）和支架植入术组（II组）。评估肾脏扩张、实质厚度和感染情况。结果：II组患者在妊娠早期也有肾积水（p p = 0.033），肾实质厚度较低（p p）。结论：妊娠相关性肾积水的支架植入术指标包括肾实质厚度≤20mm、肾扩张bb0 ~ 30mm、早期症状、感染等。
Hydronephrosis in pregnancy: Critical factors determining urinary catheter use.
Background: Pregnancy causes physiological changes, including ureteral compression by the enlarged uterus, leading to hydronephrosis in 90% of cases, though only 3% are symptomatic. This study evaluates outcomes in pregnant women with hydronephrosis managed with or without ureteral stenting to define criteria for intervention.
Methods: A retrospective analysis of 92 symptomatic pregnant women with hydronephrosis diagnosed at MP Hospital (2019-2024) was conducted. Patients were categorized into conservative treatment (Group I) and stenting (Group II). Renal dilation, parenchymal thickness, and infection status were assessed.
Results: Patients in Group II also had hydronephrosis at earlier gestational weeks (p < .001), and also had more male fetuses (p = .033), lower parenchymal thickness (p < .001), and higher infection rates (p < .001).
Conclusion: Indicators for stenting in pregnancy-related hydronephrosis include parenchymal thickness ≤20 mm, renal dilation >30 mm, early symptoms, and infections.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
